Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
What to Do when the “Lights” Don’t Work-
Neonatal Hyperbilirubinemia
Dr G Elske Hildes-RipsteinDept of Child Health and Pediatrics
University of Manitoba, College of Medicine
Annual Scientific Assembly; April 19/2018
No Conflict of Interest to declare
Objectives
• Review current delivery of phototherapy-biliblankets/fibreoptic light source
• Trouble-shoot “nonresponse “ to phototherapy
• Recognize when to consult pediatrics/neonatology for NICU admission +-exchange transfusion
Why Treat Hyperbilirubinemia?
Acute Bilirubin Encephalopathy
Kernicteris
From Neuropathology –web.org T2 signal in globus pallidus
Bilirubin staining: kernicteris
Still a Problem in Canada? Yes!
• *Sgro, CMAJ 2006 : 1/2480 “critical” hyperbilirubinemia. CPS Surveillance (excludes Rh)
• Ethnicity: 55.4% White, Asian 24.3% ,Aboriginal 7.6% ,Black 5.2%, Middle Eastern 4.0%, Latin American 2.8% , Other 1%
• Etiology: 20%- ABO incompatibility; 10% G6PD; 67% unidentified etiology
• Treatment: 22.1% exchange transfusion; 99.7% recieved phototherapy
• Outcome: 20% abn neuro outcome at discharge(hearing loss, seizures,motor)
Universal Bilirubin Screening >24 hours age and od until discharge
• Identifies infants at higher risk of needing phototherapy
• Can plan close follow-up as necessary
• Can start phototx earlier (see only in white skinned infant at 160mmol/L and poor concordance between observers)
• Better outcomes for infants ie decreased incidence of critical bilirubin >425mmo/L
• Decreased Bilirubin Encephalopathy + Kernicteris
Bhutani Nomogram of Risk level for subsequent hyperbilirubinmia
Transcutaneous Bilirubin Measurement
• How accurate?– best with same machine, on same infant, same site,
experienced user
• Useful to avoid continuous heel pokes/blood draws in infants and premature infants when assessing total neonatal bilirubin (direct + indirect) frequently
• Often used interchangeably with total Serum bilirubin for establishing whether should consider phototherapy not used to start or during phototx
• Can use again > 16 hrs post phototx
Initiating Phototherapy at hr specific threshold
• Risks; Minimal Increased temperature/increased water loss, bonding issues? other unknown? (4 decades of neonatal tx NO serious adverse clinical effects in infants.)
• Benefits; Effective >80% in avoiding Exchange transfusion
• Contraindications; if bilirubin is conjugated and use phototx get “bronzed baby syndrome”
Porphyria or Photosensitizing drugs
Guidelines for phototherapy in infants of 35 or more weeks’ GA
Subcommittee on Hyperbilirubinemia et al. Pediatrics
2004;114:297-316
©2004 by American Academy of Pediatrics
Initiating Phototherapy-other investigations?
• Consider Etiology of HyperbilirubinemiaOther investigations needed?
-serum Tbili and Dbili –base treatment decisions on serum levels only
- Signs of Sepsis? septic work up or partial septic w/u needed?
- Hemolysis? CBC+ smear, Direct Antibody Test (coombs), Blood type, G6PD
Appropriate Phototherapy Devices
Phototherapy bed: Medela Bilibed Phototherapy*: 30 μW/cm2/nm Phototherapy Blanket: Ohmeda Biliblanket Plus*: 33.75 – 56.25 μW/cm2/nm (setting can be dialed up or down) Ohmeda Bilisoft biliblanket (with cover)**: Small pad 50 μW/cm2/nm; Large pad 35 μW/cm2/nm Spot light phototherapy: Ohmeda Giraffe Spot PT lite**: 30-40 μW/cm2/nm when source 15 inches above infant
NOTE: The phototherapy units below do NOT provide adequate amounts of phototherapy. Air-Shields Vickers Phototherapy bank of overhead lights*: Average 13-14 microwatts, minimum 10 μW/cm2/nm
Bili Blanket Use
“Nonresponse” to phototherapy
1. Interpretation; Bilirubin stays same level or even rises2. Infant spends no time skin exposed to fiberoptic light
source (biliblanket)3. Load of unbound bilirubin too large for enterohepatic
circulation/disposala) hemolysing rapidlyb) significant bruising or large cephalohematomac)slow enteral transit time (1st day feeding and small
amounts)d)exclusive Breast feeding (inhibition of bilirubin
conjugation)e) relatively low albumin levels (physiologic)
Interpretation of bilirubin level
• Same or rising bilirubin level in spite of phototherapy
– Depends on infant’s hour of age ie whether on sloped part of trajectory or plateau
Eg 257 mmol/L in 39 week GA infant at 24h
Interpretation; Needs phototherapy initiated
Eg 257 mmol/L in 39 week GA infant at 48 h or 72 h
Interpretation; improving @ 72 may discontinue
Guidelines for phototherapy in infants of 35 or more weeks’ GA
Subcommittee on Hyperbilirubinemia et al. Pediatrics
2004;114:297-316
©2004 by American Academy of Pediatrics
Interpretation of bilirubin level
• Same or rising bilirubin level in spite of phototherapy– Depends on infant’s hour of age ie whether on
sloped part of trajectory or plateau
Eg 171 mmol/L in 39 week GA infant at 36h
Interpretation; No phototherapy needed
Eg 257 mmol/L in 39 week GA infant at 48 hInterpretation; start phototherapy
Eg 302 mmol/L in 39 week GA infant at 72 h
Interpretation; following usual trajectory-response
Guidelines for phototherapy in infants of 35 or more weeks’ GA
Subcommittee on Hyperbilirubinemia et al. Pediatrics
2004;114:297-316
©2004 by American Academy of Pediatrics
Infant has inadequate time or inadequate skin exposed to light
• Small baby and large diaper (Diaper covering much of back)
• Hat; therefore (large)amount of skin on head not in contact with light
• Interruptions/difficulty with holding or feeding baby with fiberoptic lights in place
• Not understanding medical need for phototherapy
(Non) Delivery of Phototherapy
What’s wrong with this picture????
Checklist for Optimal administration of Phototherapy
• Light Source (wavelength 460-490nm; blue green light region)
• Light Irradiance (>30µW/cm2/nm) and ensure uniformity over footprint
• Body Surface Area- expose maximal skin (reduce light blockage; hat,tape, diaper,probe)
• Continuity of therapy- No interruption for feeding, nursing or parental care/bonding until documented decrease in bilirubin 4-6 hours
3. Load of unbound bilirubin too large for enterohepatic circulation/disposal
a) hemolysing rapidly; bilirubin rising >8mmol/hr
b) significant bruising or large Cephalohematomaplus
c) slow enteral transit time (1st day feeding and small amounts) plus
d) exclusive Breast feeding (inhibition of bilirubin conjugation by glucuronyl transferase) plus
e) relatively low albumin levels (physiologic)
OR COMBINATION MANY FACTORS!
Additional Management Options
• Dehydration? Supplemental enteral feeds (EBM, DBM, formula) Preferred as encourages passage of stool and decreased reabsorption bilirubin) or IV fluids
• 0- 24 h; 65 cc/kg/day (9cc/h for 3.5 kg- 25cc q 3h)
• 24-48h; 80 cc/kg/day
• 48-72h; 100cc/kg/day
• 72-96h; 120cc/kg/day
• 96-120h; 150cc/kg/day
2nd Phototherapy Source
Giraffe Spotlight
Additional Management Options (2)
• Consider Sepsis……
• Low albumin (< 22)? Consider IV infusion of albumin to increase protein binding and prevent from crossing Blood Brain Barrier
• If isoimmune hemolysis or within 35mmol Exchange level; give IVIG
When to consult for Advice/Transfer
• Trajectory or slope of serial bilirubins rising iebrisk hemolysis- may need cardiorespiratory support if severe anemia
• Needs Exchange Transfusion or close to hour specific Exchange Level for Gestational Age/ neurotoxic risk factors
• Other management options not available at institution needed; ie use of IVIG infusion, “giraffe” spot light (requires 1:1 or 1:2 nursing)
QUESTIONS? COMMENTS?
DSM Lab Update on Reporting Serum Bilirubin
• Effective April 17/18 for infants 30 days to 3 months
• Report a Direct Bilirubin for every value over 17 mmol/L. If Dbili >20% Tbili; comment……
“….. Elevation of DBili is pathologic. Prompt evaluation for neonatal cholestasis needed……discus with Ped GI or Peds…….
• < 30 days only ordered Bilirubin test done ieTbili only is default (Direct only if ordered)
References
1. Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or more Weeks of gestation. Bhutani V.K. and Comittee on Fetus and Newborn; Pediatrics 2011;128;e1046
2. Management of Hyperbilirubinemia in the Newborn Infant 35 or more weeks of gestation. American Academy of Pediatrics; Subcommittee on Hyperbilirubinemia. Pediatrics 2004;114(1):297-316
3. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks’ gestation). Canadian Pediatric Society Position Statement (FN2007-02) Paediatrics and Child Health 2007;12 Suppl B 1-12.
WRHA Home Phototherapy Program
• Enrollment Criteria-term infant >48 hours old
-TSB requiring photo but not exceeding level by> 50mmol
-Coomb’s test or DAT neg
-no significant dehydration (wt loss <10%)
-passing urine and stool
-no co-morbidities; clinically stable
-Pt lives within Winnipeg (PHN program for daily F/U-clinical assessment of hydration, wt and daily TSB )
-parent’s consent